289 related articles for article (PubMed ID: 19995919)
1. Ineffectiveness of tigecycline against persistent Borrelia burgdorferi.
Barthold SW; Hodzic E; Imai DM; Feng S; Yang X; Luft BJ
Antimicrob Agents Chemother; 2010 Feb; 54(2):643-51. PubMed ID: 19995919
[TBL] [Abstract][Full Text] [Related]
2. Persistence of Borrelia burgdorferi following antibiotic treatment in mice.
Hodzic E; Feng S; Holden K; Freet KJ; Barthold SW
Antimicrob Agents Chemother; 2008 May; 52(5):1728-36. PubMed ID: 18316520
[TBL] [Abstract][Full Text] [Related]
3. Resurgence of persisting non-cultivable Borrelia burgdorferi following antibiotic treatment in mice.
Hodzic E; Imai D; Feng S; Barthold SW
PLoS One; 2014; 9(1):e86907. PubMed ID: 24466286
[TBL] [Abstract][Full Text] [Related]
4. Persistence of borrelial DNA in the joints of Borrelia burgdorferi-infected mice after ceftriaxone treatment.
Yrjänäinen H; Hytönen J; Hartiala P; Oksi J; Viljanen MK
APMIS; 2010 Sep; 118(9):665-73. PubMed ID: 20718718
[TBL] [Abstract][Full Text] [Related]
5. Fate of Borrelia burgdorferi DNA in tissues of infected mice after antibiotic treatment.
Malawista SE; Barthold SW; Persing DH
J Infect Dis; 1994 Nov; 170(5):1312-6. PubMed ID: 7963735
[TBL] [Abstract][Full Text] [Related]
6. Detection of attenuated, noninfectious spirochetes in Borrelia burgdorferi-infected mice after antibiotic treatment.
Bockenstedt LK; Mao J; Hodzic E; Barthold SW; Fish D
J Infect Dis; 2002 Nov; 186(10):1430-7. PubMed ID: 12404158
[TBL] [Abstract][Full Text] [Related]
7. Immunoglobulin-regulated expression of Borrelia burgdorferi outer surface protein A in vivo.
Hodzic E; Tunev S; Feng S; Freet KJ; Barthold SW
Infect Immun; 2005 Jun; 73(6):3313-21. PubMed ID: 15908357
[TBL] [Abstract][Full Text] [Related]
8. Borrelia burgdorferi outer surface protein (osp) B expression independent of ospA.
Liang FT; Caimano MJ; Radolf JD; Fikrig E
Microb Pathog; 2004 Jul; 37(1):35-40. PubMed ID: 15194158
[TBL] [Abstract][Full Text] [Related]
9. Modification of Borrelia burgdorferi to overproduce OspA or VlsE alters its infectious behaviour.
Xu Q; McShan K; Liang FT
Microbiology (Reading); 2008 Nov; 154(Pt 11):3420-3429. PubMed ID: 18957595
[TBL] [Abstract][Full Text] [Related]
10. Spirochete antigens persist near cartilage after murine Lyme borreliosis therapy.
Bockenstedt LK; Gonzalez DG; Haberman AM; Belperron AA
J Clin Invest; 2012 Jul; 122(7):2652-60. PubMed ID: 22728937
[TBL] [Abstract][Full Text] [Related]
11. A reverse transcriptase-polymerase chain reaction assay of Borrelia burgdorferi 16S rRNA for highly sensitive quantification of pathogen load in a vector.
Ornstein K; Barbour AG
Vector Borne Zoonotic Dis; 2006; 6(1):103-12. PubMed ID: 16584333
[TBL] [Abstract][Full Text] [Related]
12. Anti-tumor necrosis factor-alpha treatment activates Borrelia burgdorferi spirochetes 4 weeks after ceftriaxone treatment in C3H/He mice.
Yrjänäinen H; Hytönen J; Song XY; Oksi J; Hartiala K; Viljanen MK
J Infect Dis; 2007 May; 195(10):1489-96. PubMed ID: 17436229
[TBL] [Abstract][Full Text] [Related]
13. Antigenic and genetic heterogeneity of Borrelia burgdorferi populations transmitted by ticks.
Ohnishi J; Piesman J; de Silva AM
Proc Natl Acad Sci U S A; 2001 Jan; 98(2):670-5. PubMed ID: 11209063
[TBL] [Abstract][Full Text] [Related]
14. Detection of Borrelia burgdorferi nucleic acids after antibiotic treatment does not confirm viability.
Iyer R; Mukherjee P; Wang K; Simons J; Wormser GP; Schwartz I
J Clin Microbiol; 2013 Mar; 51(3):857-62. PubMed ID: 23269733
[TBL] [Abstract][Full Text] [Related]
15. Borrelia burgdorferi population kinetics and selected gene expression at the host-vector interface.
Hodzic E; Feng S; Freet KJ; Borjesson DL; Barthold SW
Infect Immun; 2002 Jul; 70(7):3382-8. PubMed ID: 12065476
[TBL] [Abstract][Full Text] [Related]
16. Temporal changes in outer surface proteins A and C of the lyme disease-associated spirochete, Borrelia burgdorferi, during the chain of infection in ticks and mice.
Schwan TG; Piesman J
J Clin Microbiol; 2000 Jan; 38(1):382-8. PubMed ID: 10618120
[TBL] [Abstract][Full Text] [Related]
17. Generality of Post-Antimicrobial Treatment Persistence of
Hodzic E; Imai DM; Escobar E
Infect Immun; 2019 Oct; 87(10):. PubMed ID: 31308087
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of Borrelia burgdorferi-tick interactions in vivo by outer surface protein A antibody.
Pal U; Montgomery RR; Lusitani D; Voet P; Weynants V; Malawista SE; Lobet Y; Fikrig E
J Immunol; 2001 Jun; 166(12):7398-403. PubMed ID: 11390491
[TBL] [Abstract][Full Text] [Related]
19. Culture of the entire mouse to determine whether cultivable Borrelia burgdorferi persists in infected mice treated with a five-day course of Ceftriaxone.
Pavia CS; Wormser GP
Antimicrob Agents Chemother; 2014 Nov; 58(11):6701-3. PubMed ID: 25155590
[TBL] [Abstract][Full Text] [Related]
20. Destruction of spirochete Borrelia burgdorferi round-body propagules (RBs) by the antibiotic tigecycline.
Brorson Ø; Brorson SH; Scythes J; MacAllister J; Wier A; Margulis L
Proc Natl Acad Sci U S A; 2009 Nov; 106(44):18656-61. PubMed ID: 19843691
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
